Long noncoding RNAs (lncRNAs) are a class of noncoding, endogenous, single- ZNFX1 antisense RNA 1 (ZFAS1), a novel lncRNA transcribed in the antisense orientation of zinc finger NFX1-type containing 1(ZNFX1), was found to be increased in multiple cancers, such as gastric cancer and hepatocellular carcinoma, contributing to cancer development and progression. In the present review, we summarized recent progression on study of the functions and underlying molecular mechanisms of ZFAS1 related to occurrence and development of multiple cancers.
| INTRODUC TI ON
Recently, due to increasing incidence and mortality, cancer is one of the leading public health problems all over the world and continues to capture our great attention. 1 In the light of estimates in a comprehensive overview called Cancer Statistics, 2017, there were 1 688 780 new patients predicted to be diagnosed with cancers and 600 920 patients were predicted to die of cancers in the United States are predicted to occur in 2017. 2 In China, there were an estimated 4 292 000 new cancer patients and 2 814 000 patients who died of cancers have occurred in 2015. 3 Despite multiple treatments modalities being accessible for cancer patients, including surgery, chemotherapy, radiation therapy, and targeted therapy, the 3-and 5-year cancer-specific survival rates still remain poor. 1, 4 Exploration of and revealing the molecular mechanisms important to cancer is therefore critical in order to identify new diagnostic and prognostic biomarkers as well as effective treatments.
Less than 2% of genes are associated with the production of specific proteins according to eukaryote whole-genome sequencing. 5 Furthermore, more than 70% of identified genes had no protein-coding function. 5 At first, such noncoding RNAs (ncRNAs)
were considered to be transcriptional noise with no specific biological function. 6 With further research of ncRNAs, however, they have been identified as indispensable regulators of a variety of biological processes, including epigenetics, cell cycle, posttranscriptional regulation and chromatin modification. [6] [7] [8] Although we currently lack satisfactory classifications for these ncRNAs, long ncRNAs are arbitrarily considered to be longer than 200 nucleotides. 6, 9 Mounting evidence has indicated that lncRNA plays key roles in physiological and pathological processes by modifying gene expression at the transcriptional, posttranscriptional, epigenetic, and translation levels. [6] [7] [8] Several reports have demonstrated that lncRNAs could function as potential oncogenes or tumour suppressor genes in order to play vital regulatory roles in tumourigenesis and tumour progression. 10, 11 ZNFX1 antisense RNA 1 (ZFAS1), a novel lncRNA transcribed from the antisense orientation of zinc finger NFX1-type containing 1(ZNFX1), is located on chromosome 20q13.13 ( Figure 1 ). 12 Recent research has reported that ZFAS1 may act an emerging regulatory factor in multiple diseases, such as acute myocardial infarction, 13, 14 rheumatoid arthritis, 15 and cancer. 16 Accumulating evidence has suggested that the abnormal expression of ZFAS1 contributes to the occurrence and development of various cancers, including gastric cancer, hepatocellular carcinoma, colorectal cancer, glioma, osteosarcoma, ovarian cancer, acute myeloid leukaemia, nonsmall cell lung cancer (NSCLC), oesophageal squamous cell carcinoma, and breast cancer. In this review, we summarized recent progression regarding study of the functions and underlying mechanisms of ZFAS1 in the occurrence and development of various cancers.
| D ISCOVERY OF ZFA S1
ZFAS1, firstly studied in breast cancer by Marjan, is transcribed from the gene ZNFX1 on the antisense DNA strand near the 5′ The functions and underlying molecular mechanisms of ZFAS1 in various cancers are summarized in Table 2 and detailed in the rest of this review. 
| Colorectal cancer

| Gastric cancer
Current research trends have explored the function and molecular mechanisms of ZFAS1in gastric cancer. Zhou et al, 25 Pan et al, 26 and
Nie et al 27 
| Hepatocellular carcinoma
Li et al 28 
| Glioma
| Osteosarcoma
In osteosarcoma tissues and cell lines, Liu et al and Li et al 32, 33 showed that ZFAS1 was markedly upregulated. Kaplan-Meier analysis suggested that osteosarcoma patients with high ZFAS1 levels had shorter overall survival (OS) than those with low ZFAS1. Functional experiments revealed that upregulated ZFAS1 promoted osteosarcoma cell proliferation, migration, and invasion in vitro and in vivo.
Mechanistically, the researchers discovered that 
| Ovarian cancer
A report by Xia et al 34 
| Acute myeloid leukaemia
When compared with normal cell lines, Guo et al 30 
| Nonsmall cell lung cancer
| Breast cancer
Marjan et al 12 
| Transcriptional regulation
Further research has demonstrated that ZFAS1 could simultaneously interact with EZH2 and LSD1/CoREST to inhibit KLF2 and NKD2
transcription. Rescue experiments revealed that ZFAS1 was partly relied on suppressing KLF2 and NKD2 expression to exert its oncogenic effects ( Figure 2G ). SP1 was also demonstrated to be an upstream factor for the activation of ZFAS1 expression ( Figure 2H ). Moreover,
Hansji et al showed that ZFAS1 was induced upon ribosome biogenesis, revealing a role in synthesis or assembly of ribosomes.
| ZFAS1 is involved in several signalling pathways
| EMT signalling pathway
EMT plays an essential role in both physiological and pathological processes, such as embryonic development as well as the occurrence and development of tumours. 40, 41 Several EMT markers are indispensable in the EMT signalling pathway, including MMP2, MMP9, E-cadherin, N-cadherin, Integrin β1, ZEB1/2, Twist, and Snail. 41 After silencing of ZFAS1, the expression levels of MMP2, MMP9, Ncadherin, Integrin β1, ZEB1, Twist, and Snail were all markedly downregulated, while E-cadherin expression significantly upregulated. In conclusion, Liu et al also showed that ZFAS1 interacted with ZEB2 to protect ZEB2 protein stability in the activation of the EMT signalling pathway.
| Notch signalling pathway
The Notch signalling pathway functions as a vital regulator in embryo development via the regulation of intercellular signal communication by modifying cell proliferation and apoptosis [42] [43] [44] ; both Hes-1 and NICD have vital functions in Notch signalling pathway. 44 , 45 Gao et al found that the expression Notch signal-related proteins Hes-1 and NICD were decreased by silencing ZFAS1in glioma cell, suggesting ZFAS1 could regulate the expression of Hes-1 and NICD to activate Notch signalling pathway ( Figure 2E ).
| p53 signalling pathway
The p53 protein, a nuclear transcription factor, modified the expression of multiple genes which are involved in a variety of biological processes, including the cell cycle, apoptosis, and DNA repair. 46 Thorenoor et al demonstrated that decreased ZFAS1 contributed to cell-cycle arrest and induction of apoptosis by reducing the expression of p53 and cyclin B1 and promoting PARP cleavage ( Figure 2F ).
This finding suggests that ZFAS1 activated the p53 signalling pathway to act oncogenic roles in various cancers.
| CON CLUS I ON AND FUTURE PER S PEC TIVE S
With the rapid development of next-generation sequencing technology, a large amount of evidence has identified dysregulated lncRNAs as potential oncogenes or tumour suppressor genes that play crucial regulatory roles in tumourigenesis and tumour progression. 47, 48 ZFAS1, a newly identified lncRNA, was found to be widely upregulated in various human cancers (expect breast cancer). 
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